These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8335304)

  • 1. [Anti-ischemic therapy with verapamil. Improving prognosis by secondary prevention after acute myocardial infarct].
    Dotzer F; Gromer H
    Fortschr Med; 1993 May; 111(14):245-8. PubMed ID: 8335304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardioprotection with drugs. 1: Coronary heart disease].
    Michel D
    Fortschr Med; 1990 Jan; 108(3):40-4. PubMed ID: 1968878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium antagonists and coronary heart disease. An overview].
    Gasser R; Eber B; Schwarz T; Schafhalter E; Klein W
    Wien Med Wochenschr; 1993; 143(19-20):500-9. PubMed ID: 8135032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Silent myocardial ischemia and nitrates].
    Palma Gámiz JL
    Ann Cardiol Angeiol (Paris); 1997; 46(7):431-40. PubMed ID: 9452778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress regarding nitrates and their use in stable and unstable angina pectoris, pre-infarction syndrome and myocardial infarct].
    Lichtlen PR
    Internist (Berl); 1992 Oct; 33(10):684-94. PubMed ID: 1428686
    [No Abstract]   [Full Text] [Related]  

  • 7. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of cardiovascular therapy on risk of the development of ischemia and myocardial infarction in the postoperative period in cancer patients with ischemic heart diseases].
    Stetsenko AE; Kassil' VL; Ushakova TI
    Anesteziol Reanimatol; 2001; (5):55-7. PubMed ID: 11757304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical considerations in the use of calcium entry blockers in silent myocardial ischemia.
    Crawford MH
    Circulation; 1989 Dec; 80(6 Suppl):IV74-7. PubMed ID: 2574641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists after acute myocardial infarction.
    Ferrario M; Specchia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S75-8. PubMed ID: 2483238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of verapamil for correcting the hemodynamic disorders in the acute period of a myocardial infarct].
    Molodan VI; Kopitsa NP; Dykun IaV; Zarivchatskaia IT
    Vrach Delo; 1990 Sep; (9):6-8. PubMed ID: 2126649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary prevention of myocardial infarct with beta blockers].
    Vacheron A; Baubion N; Delage F
    J Pharmacol; 1983; 14 Suppl 2():169-75. PubMed ID: 6138466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium antagonists in cardiovascular diseases].
    Thuillez C
    Arch Mal Coeur Vaiss; 1995 Sep; 88 Spec No 4():9-12. PubMed ID: 7503623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The comparative efficacy of verapamil, nifedipine and propranolol in patients with IHD and an enhanced risk of a fatal outcome].
    Mazur NA; Pavlova TS; Vasil'eva NN; Kul'ginskaia IV
    Ter Arkh; 1994; 66(8):26-30. PubMed ID: 7527161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium inhibitors and myocardial ischemia].
    Thuillez C
    Therapie; 1993; 48 Spec No():671-6. PubMed ID: 8091353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial.
    Hansen JF
    J Hypertens Suppl; 1998 Jan; 16(1):S71-4. PubMed ID: 9534101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.